AALL1631, International phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbones

IRB/UVA Tracking #
21121
Contact
Candace K Hudspeth
Contact Email
Contact Phone
1.434.982.1091
Phase
III
Primary purpose
Treatment
Cancer PI
William C. Petersen
Status
OPEN TO ACCRUAL